Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 47,725 | 37,497 | 31,598 | 27,906 | 18,780 |
| Cost of Goods | 10,228 | 6,812 | 4,979 | 4,494 | 2,932 |
| Gross Profit | 37,497 | 30,685 | 26,619 | 23,412 | 15,848 |
| Operating Expenses | 62,873 | 55,770 | 54,746 | 58,067 | 49,662 |
| Operating Income | -25,148 | -24,273 | -27,148 | -34,161 | -32,882 |
| Interest Expense | 3,574 | 3,726 | 4,242 | 4,359 | 3,971 |
| Other Income | 5,383 | -45,723 | 1,461 | 2,229 | 1,160 |
| Pre-tax Income | -23,339 | -73,722 | -29,929 | -36,291 | -35,693 |
| Income Tax | 249 | 316 | 201 | 140 | 13 |
| Net Income Continuous | -23,588 | -74,038 | -30,130 | -36,431 | -35,706 |
| Net Income | $-23,588 | $-74,038 | $-30,130 | $-36,431 | $-35,706 |
| EPS Basic Total Ops | -0.57 | -1.94 | -0.80 | -0.98 | -1.02 |
| EPS Basic Continuous Ops | -0.57 | -1.94 | -0.80 | -0.98 | -1.02 |
| EPS Diluted Total Ops | -0.57 | -1.94 | -0.80 | -0.99 | -1.02 |
| EPS Diluted Continuous Ops | -0.57 | -1.94 | -0.80 | -0.96 | -1.02 |
| EBITDA(a) | $-22,075 | $-22,630 | $-25,811 | $-32,960 | $-31,786 |